👨‍⚕️ ChatGPT the MD

Happy Tuesday!

ChatGPT has been playing doctor again — this time with a 72% success rate. And a full team of ex-Meta researchers have just secured $40M for their AI Biotech startup.

Let’s Review 👇

👨‍⚕️ ChatGPT Has a 72% Success Rate in Clinical Decision-making

AI capabilities in medical scenarios are still controversial among doctors.

However, a study from Mass General Brigham found that ChatGPT achieved 72% accuracy in clinical decision-making. Given the study, AI could improve diagnosis efficiency and accuracy as healthcare becomes more expensive and complex.

The study assessed ChatGPT's performance across the full scope of clinical care. ChatGPT got the final diagnosis right 77% of the time, but its success rate dropped to 60% in cases requiring an understanding of all the possible conditions.

Another study found that ELDER-ICU can assist in identifying the severity of illness in older adults. AI has outperformed medical professionals in some tasks, but its real-world application is limited. AI tests in research settings have no risk of malpractice lawsuits.

More research and regulatory guidance is needed for AI models to be deployed in hospitals, and diagnostic success rates need to rise to 80-90%. (Read More)

YOUR DAILY TOOL 🛠

Josh - is a voice-controlled AI system that can be used to control various smart home devices

Sponsored Partner

💼 How to Stay Competitive in the AI Job Market

Want to stay ahead of the AI curve?

Unleash the potential of AI across industries such as healthcare, law, and security, while mastering the art of responsible AI implementation with an AI Executive Certificate from MIT Sloan.

Over their six-week short course, you can explore the immense capabilities of machine learning (ML) tools, uncover their vulnerabilities, and learn to construct robust systems giving you a significant AI advantage. (Read More)

💰 ex-Meta Researchers Secure $40M for Their AI Biotech Startup

Former Meta researchers have launched a new startup called EvolutionaryScale and just secured $40M. Led by Alexander Rives, the founding staff of eight developed an AI language model for biology similar to OpenAI's GPT-4.

They trained the model on protein molecule data to predict the structures of unknown proteins, resulting in a database with 700 million possible 3D structures.

The startup pitched venture capitalists for seed financing to scale up its AI model. Lux Capital led the $40 million round, valuing EvolutionaryScale at $200 million.

The ability to predict protein structures is crucial for new drug development. DeepMind's AlphaFold made a significant impact in 2020 with its AI system for predicting protein structures.

EvolutionaryScale hopes to build the next-generation platform for bio research. (Read More)

YOUR DAILY JOKE 🤣

FEATURED INNOVATORS 🚀 

• Deepgram - has an AI startup program to help technical founders create, launch, and scale AI voice-enabled experiences with speech recognition.

  *(Visit)

• BioSymetrics - uses AI and in vivo validation to discover higher-confidence targets and precision medicines faster.

  (Visit)

• InformAI - is a cutting-edge AI company specializing in healthcare solutions to improve medical diagnosis.

  (Visit)

• Salience Labs - is building the next generation of faster chips to grow AI capability.

  (Visit)

• Subtle Medical - has developed a suite of deep-learning software solutions that take radiology workflow to the next level.

  (Visit)

*Sponsored Partner

That’s all for today!

As always, if you have feedback, new information, or want to collaborate please let me know.

P.S. Connect with me on LinkedIn.